Cardiopulmonary bypass (CPB) is a form of extracorporeal circulation in which the patient's blood is diverted from the heart and lungs and rerouted outside of the body. The normal physiologic functions of the heart and lungs, including circulation of blood, oxygenation, and ventilation, are temporarily taken over by the CPB machine. In most cases, the heart is also separated from the circulation (eg, aortic cross-clamping) and cardioplegia solution is administered to allow the cardiac surgeon to operate on a nonbeating heart in a field largely devoid of blood, while other end organs remain adequately oxygenated and perfused.
This report contains market size and forecasts of Heart Lung (Cardiopulmonary) Bypass Machine in global, including the following market information:
Global Heart Lung (Cardiopulmonary) Bypass Machine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Heart Lung (Cardiopulmonary) Bypass Machine Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Heart Lung (Cardiopulmonary) Bypass Machine companies in 2021 (%)
The global Heart Lung (Cardiopulmonary) Bypass Machine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Single Roller Pump Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Heart Lung (Cardiopulmonary) Bypass Machine include LivaNova, Getinge, Medtronic, Terumo, Braile Biomedica and Tianjin Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Heart Lung (Cardiopulmonary) Bypass Machine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Heart Lung (Cardiopulmonary) Bypass Machine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Heart Lung (Cardiopulmonary) Bypass Machine Market Segment Percentages, by Type, 2021 (%)
Single Roller Pump
Double Roller Pump
Global Heart Lung (Cardiopulmonary) Bypass Machine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Heart Lung (Cardiopulmonary) Bypass Machine Market Segment Percentages, by Application, 2021 (%)
Cardiac Surgery
Lung Transplant Operation
Other
Global Heart Lung (Cardiopulmonary) Bypass Machine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Heart Lung (Cardiopulmonary) Bypass Machine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Heart Lung (Cardiopulmonary) Bypass Machine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Heart Lung (Cardiopulmonary) Bypass Machine revenues share in global market, 2021 (%)
Key companies Heart Lung (Cardiopulmonary) Bypass Machine sales in global market, 2017-2022 (Estimated), (Units)
Key companies Heart Lung (Cardiopulmonary) Bypass Machine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
LivaNova
Getinge
Medtronic
Terumo
Braile Biomedica
Tianjin Medical